Susquehanna International Group, LLP Design Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$3.19 - $5.88 $1,595 - $2,940	-500 Reduced 3.5%	13,800 $74,000
Q2 2024 Aug 15, 2024	BUY	$3.23 - $4.77 $46,189 - $68,211	14,300 New	14,300 $47,000
Q4 2023 Feb 14, 2024	SELL	$1.99 - $2.76 $5,970 - $8,280	-3,000 Reduced 2.45%	119,600 $316,000
Q3 2023 Nov 14, 2023	BUY	$2.05 - $8.14 $251,329 - $997,964	122,600 New	122,600 $289,000
Q4 2022 Feb 14, 2023	SELL	$7.86 - $17.2 $29,868 - $65,360	-3,800 Reduced 20.32%	14,900 $152,000
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $263,483 - $478,159	18,700 New	18,700 $313,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $314M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.